In a flurry of meetings with federal officials, drug industry and provider groups are making a final push to influence [...] …
Category: Trade Association
Johnson & Johnson (J&J) has formally appealed a federal judge’s ruling that drugmakers cannot unilaterally implement a 340B rebate model—a [...] …
In their second emergency motion this month, a group of drugmakers is urging a federal appeals court to reject a [...] …
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...] …
A federal appellate court in Washington, D.C. is fast-tracking Novartis and Bristol Myers Squibb’s (BMS) appeal of a lower court [...] …
In the final hour of Oklahoma’s 2025 legislative session, as the clock neared 11 p.m. on May 29, state legislators [...] …
There’s a gap in economics research on the 340B program, and economists could enrich 340B stakeholders’ understanding of the program [...] …
AstraZeneca and the brand-name drug industry’s leading trade group have filed federal lawsuits challenging newly enacted 340B contract pharmacy access [...] …
A federal judge’s decision to uphold the government’s authority to pre-approve drugmaker 340B rebate models has drawn praise from providers, [...] …
A federal district judge last Friday allowed a key hospital trade group to intervene in Johnson & Johnson’s (J&J) lawsuit [...] …